Recombinant Human BD-2 Protein，His & GST

BD-2 (defensin beta-2) is a member of the defensin family, small cationic peptides that play crucial roles in the innate immune response. Discovered primarily within human epithelial tissues, BD-2 exhibits antimicrobial properties against a wide range of pathogens, including bacteria, fungi, and viruses, making it a vital component of the host defense system. Research into BD-2 has gained momentum due to its potential applications in therapeutic development, especially in combating antibiotic-resistant infections and enhancing wound healing. Studies have shown that BD-2 can be upregulated in response to inflammatory stimuli, indicating its role in modulating immune responses. Furthermore, its expression correlates with various diseases, including infections and inflammatory conditions, highlighting its significance as a biomarker. The recombinant expression of BD-2 allows for further investigation of its biological functions and properties, paving the way for potential clinical applications. Investigating the structure-function relationship of BD-2 aids in understanding how variations in its sequence affect its antimicrobial activity, stability, and interactions with microbial membranes. Overall, BD-2 research is at the forefront of immunology and therapeutic development, with the promise of yielding novel strategies for managing infectious and inflammatory diseases.